Report Description

Metformin is an antihyperglycemic drug which is used in the treatment of type 2 diabetes and polycystic ovarian syndrome (PCOS). The drug functions by reducing blood glucose levels in type 2 diabetes without causing hypoglycemia. In PCOS patients, the drug functions by reducing weight and androgen levels. The drug helps in restoring ovulation and minimizes the risk of miscarriage also.

India metformin market is expected to grow at a steady rate during the forecast period. The India metformin market is driven by the growing prevalence of diabetes in the country, especially among the geriatric population. According to the International Diabetes Federation, as of 2020, there are around 77 million people in the country suffering from diabetes. India has the second largest patient population suffering from diabetes after China. Additionally, initiatives taken by the Government of India such as the China-plus-one strategy are further expected to create lucrative opportunities for the market growth through FY2026. This strategy involves identification of essential active drug ingredients and providing incentives to the indigenous manufacturers in the country. This not only will help in reviving the status of domestic players but also help India in becoming an alternative active pharmaceutical ingredients (APIs) supplier for drug manufacturing companies. Besides, this the government has identified 53 APIs covering around 41 products for which it will be offering incentives to the manufacturer companies, provided they setup greenfield projects.

The India metformin market is segmented based on source, type, distribution channel, application, end user, company and region. Based on type, the market can be split into immediate release tablets and extended release tablets. The extended release tablets segment is expected to hold a larger market share as compared to the immediate release tablets. This can be ascribed to the fact that extended release tablets have longer duration of action than the immediate release tablets. Also, they have lesser side-effects and are prescribed once daily after evening meal.

The major players operating in the India metformin market are Bristol-Myers Squibb India Pvt. Ltd., Teva API India Limited, Aarti Drugs Ltd., Exemed Pharmaceuticals, Wanbury Limited, USV Private Limited, Harman Finochem Limited, Aurobindo Pharma Limited, Auro Laboratories Limited, Trimax Bio Sciences Pvt. Ltd. and others. Majority of the companies are adopting advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, research collaborations and pharma licensing deals.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India metformin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India Metformin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India metformin market based on source, type, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India metformin market.
  • To identify drivers and challenges for India metformin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India metformin market.
  • To identify and analyze the profile of leading players operating in India metformin market.
  • To identify key sustainable strategies adopted by market players in India metformin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India metformin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Metformin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to Metformin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India metformin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Metformin Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Metformin Market, By Type:
    • Immediate Release Tablets
    • Extended Release Tablets
  • India Metformin Market, By Distribution Channel:
    • Online
    • Offline
  • India Metformin Market, By Application:
    • Type-2 Diabetes
    • Polycystic Ovarian Syndrome
  • India Metformin Market, By End User:
    • Children ≥10 years
    • Adults
  • India Metformin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India metformin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Metformin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Metformin Market

4.    Executive Summary

5.    Manufacturing Metformin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Metformin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Metformin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-House v/s Contract Manufacturing Organizations)

7.2.2.     By Type (Immediate Release Tablets v/s Extended Release Tablets)

7.2.3.     By Distribution Channel (Online v/s Offline)

7.2.4.     By Application (Type-2 Diabetes v/s Polycystic Ovarian Syndrome)

7.2.5.     By End User (Children ≥10 years v/s Adults)

7.2.6.     By Region (North, East, South, West)

7.2.7.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Bristol-Myers Squibb India Pvt. Ltd.      Company Brief      Production Plants & Capacity (If available)      Financials (If available)      Captive Consumption v/s Merchant Sale      Current & Future Plans

14.1.2.  Teva API India Limited

14.1.3.  Aarti Drugs Ltd.

14.1.4.  Exemed Pharmaceuticals

14.1.5.  Wanbury Limited

14.1.6.  USV Private Limited

14.1.7.  Harman Finochem Limited

14.1.8.  Aurobindo Pharma Limited

14.1.9.  Auro Laboratories Limited

14.1.10.                Trimax Bio Sciences Pvt. Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

Figures and Tables

Frequently asked questions